Mount Sinai Medical Center Leads the Way in Treating Complex Aortic Conditions with AI Technology
Mount Sinai Medical Center in South Florida has become the first institution in Eastern Florida to utilize advanced artificial intelligence (AI) technology to treat complex aortic conditions. The medical center has teamed up with Cydar Medical and Medtronic to implement a unique AI software that supports the treatment of patients with complex aortic disease.
The software integrates Cydar Maps, a cutting-edge platform, with Medtronic services and case support to enhance patient care and streamline procedures. Cydar Maps generates a detailed 3D map of the patient’s vascular system, providing precise preoperative planning, intraoperative guidance, and postoperative reviews for endovascular surgery. Through the utilization of AI, the software constantly updates the map throughout the patient’s journey, ensuring accurate and successful surgeries. This innovative technology offers a range of benefits, including reduced radiation exposure, simplified workflows, and increased clinician confidence.
Dr. Micheal Ayad, the Co-Director of the Aortic Center at Mount Sinai, expresses excitement about the integration of AI image-based guidance. This new technology reduces radiation and contrast usage, lowering the risk of kidney problems after procedures and allowing for more efficient surgeries. Dr. Ayad believes this represents the future of aortic surgery.
Cydar Medical, a UK-based company, developed the mapping platform to revolutionize how clinicians share information in image-guided minimally invasive surgery. By simplifying complexities within operating theaters globally, Cydar empowers medical professionals to provide optimal care.
Mount Sinai’s Aortic Center adopts a collaborative approach, involving cardiac surgeons, vascular surgeons, cardiologists, and geneticists, to address complex aortic and endovascular conditions. Together, they develop custom-made solutions tailored to each patient, recognizing that diseases vary significantly among individuals. This multidisciplinary approach leads to better outcomes and durability.
Paul Mussenden, CEO at Cydar Medical, expresses the company’s excitement about Mount Sinai’s adoption of their product. Mussenden believes that their software will provide surgeons with a more predictable and efficient way to perform minimally invasive, image-guided procedures, leading to optimal results for patients.
Mount Sinai Medical Center, founded in 1949, is the largest independent, private, not-for-profit teaching hospital in South Florida. It is dedicated to providing quality healthcare to a diverse community through teaching, research, charity care, and financial responsibility. With centers of excellence in cardiology, neuroscience, oncology, urology, and orthopedics, Mount Sinai combines technology, research, and academics to offer innovative and comprehensive care.
Cydar Medical, a global cloud-based software company headquartered in Cambridge, UK, offers an integrated solution for planning, navigation, and review of minimally invasive image-guided surgical procedures. Their AI-powered Cydar Maps solution enhances surgical visualization and decision-making throughout the surgical pathway, providing analytics and insights based on global procedures. With a vision to advance the quality of patient care, Cydar continues to release new products and capabilities.
As Mount Sinai Medical Center pioneers the use of AI technology in treating complex aortic conditions, patients can expect improved outcomes, reduced risks, and more efficient procedures. By leveraging AI’s power, Mount Sinai continues to lead the way in delivering state-of-the-art healthcare solutions.
